
Beta amiloide
Beta amyloid inhibitors are compounds that specifically target and inhibit the formation or aggregation of beta-amyloid peptides, which are critically involved in the pathogenesis of Alzheimer's disease. The accumulation of beta-amyloid plaques in the brain is one of the key pathological features of Alzheimer's, contributing to neuronal dysfunction, synaptic loss, and cognitive decline. By preventing the aggregation of beta-amyloid, these inhibitors are being actively researched as potential therapeutic agents aimed at slowing down or even halting the progression of Alzheimer's disease. At CymitQuimica, we offer a variety of high-quality beta-amyloid inhibitors to support your research in neurodegenerative disorders, protein aggregation, and the development of Alzheimer's therapies.
Se han encontrado 204 productos de "Beta amiloide"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Chlorzoxazone
CAS:<p>Chlorzoxazone (Chlorzoxazon) is a Muscle Relaxant. The physiologic effect of chlorzoxazone is by means of Centrally-mediated Muscle Relaxation.</p>Fórmula:C7H4ClNO2Pureza:99.49% - 99.6%Forma y color:SolidPeso molecular:169.57LY 2389575 hydrochloride
CAS:<p>LY2389575 hydrochloride is a selective mGlu3 NAM with 190 nM IC50, increases Mrc1, and aids Alzheimer's research.</p>Fórmula:C15H16BrCl3N4Pureza:99.45%Forma y color:SolidPeso molecular:438.58Gantenerumab
CAS:<p>Gantenerumab (R-1450) is a humanized antibody targeting amyloid-β (Aβ), used in studies of Alzheimer's disease.</p>Pureza:>95%Forma y color:LiquidALZ-801
CAS:<p>ALZ-801, an oral valine-prodrug of tramiprosate, enhances treatment of Alzheimer's by inhibiting β-amyloid aggregation with better PK and tolerance.</p>Fórmula:C8H18N2O4SPureza:99.36%Forma y color:SolidPeso molecular:238.3Glimepiride
CAS:<p>Glimepiride (HOE-490) is a long-acting, third-generation sulfonylurea with hypoglycemic activity.</p>Fórmula:C24H34N4O5SPureza:97.84% - 98.87%Forma y color:White Cyrstalline SolidPeso molecular:490.62Cromolyn sodium
CAS:<p>Cromolyn sodium (FPL-670) is a chromone complex that acts by inhibiting the release of chemical mediators from sensitized mast cells.</p>Fórmula:C23H14Na2O11Pureza:99.4% - 99.95%Forma y color:Colorless Crystals From Ethanol + Ether White Crystalline PowderPeso molecular:512.33Donanemab
CAS:<p>Donanemab (LY3002813), a humanized IgG1 antibody, targets N-terminal Aβ for potential early Alzheimer's research.</p>Pureza:95%Forma y color:LiquidLecanemab
CAS:<p>Lecanemab (BAN-2401) is an IgG1 monoclonal antibody targeting soluble aggregated beta amyloid (Abeta) for the study of cognitive disorders.</p>Pureza:95% - 97.3% (SEC-HPLC)Forma y color:LiquidBirtamimab
CAS:<p>Birtamimab (NEOD001) is a monoclonal antibody selectively targeting and depleting amyloid protein, used in research on light chain amyloidosis.</p>Pureza:>95%Forma y color:LiquidEprodisate disodium
CAS:<p>Eprodisate disodium (NC-503) is a negatively charged sulfonated inhibitor of fibrillogenesis, that can be used in the treatment of amyloid A (AA) amyloidosis.</p>Fórmula:C3H6Na2O6S2Pureza:99.88%Forma y color:White Coarse PowderPeso molecular:248.19β-Amyloid (35-42)
CAS:<p>β-Amyloid (35-42) is a peptide derived from the beta-amyloid protein, encompassing amino acids 35 through 42.</p>Fórmula:C33H60N8O9SPureza:98%Forma y color:SolidPeso molecular:744.94LPYFD-NH2
CAS:<p>neuroprotective peptide that binds to amyloid beta (Aβ)</p>Fórmula:C33H44N6O8Pureza:98%Forma y color:SolidPeso molecular:652.74Trontinemab
CAS:<p>Trontinemab, a bispecific humanized IgG1-κ antibody, targets the amyloid beta A4 precursor protein (APP) and transferrin receptor p90, CD71 (TFRC).</p>Pureza:96.77% - 99%Forma y color:Liquid(Gln22)-Amyloid β-Protein (1-42)
CAS:<p>(Gln22)-Amyloid β-Protein (1-42), a Dutch mutation (E22Q) variant of β-Amyloid (1-42), demonstrates increased fibrillogenic and pathogenic characteristics [1].</p>Fórmula:C203H312N56O59SForma y color:SolidPeso molecular:4513.05BSBM6
CAS:<p>BSBM6 is an inhibitor of Aβ aggregation and neuronal toxicity that acts by reversing the aggregation and toxicity of amyloid-β peptides.</p>Fórmula:C23H29N3O5Pureza:98%Forma y color:SolidPeso molecular:427.49β-Amyloid (1-40)
CAS:<p>Amyloid β1-40 is one of the fragments generated after cleavage of the amyloid peptide precursor protein by β and γ secretases.</p>Fórmula:C194H295N53O58SPureza:98%Forma y color:SolidPeso molecular:4329.82BIBD-124
CAS:<p>BIBD-124, with an IC50 value of 9.51 nM, effectively binds to amyloid beta (Aβ) plaques.</p>Fórmula:C19H24FN3O3Forma y color:SolidPeso molecular:361.41BSB
CAS:<p>BSB is a Congo red-derived fluorescent probe, an amyloid protein imaging agent, interacting with amyloid fibrils formed by Aβ (1-40) peptides in rodents.</p>Fórmula:C24H17BrO6Pureza:95.53%Forma y color:SolidPeso molecular:481.29Amyloid β Peptide (42-1)(human) acetate
<p>Amyloid β Peptide (42-1)(human) acetate is the inactive form of Amyloid β Peptide (1-42).</p>Pureza:95.20%Forma y color:Soildδ-secretase inhibitor 11
CAS:<p>δ-secretase inhibitor 11 is an inhibitor of δ-secretase and can be used as a lead compound for translational development of AD treatment.</p>Fórmula:C10H12N4O2Pureza:99.84%Forma y color:SolidPeso molecular:220.23Aβ1-14-εK-KKK-MvF5 Th
<p>Aβ1-14-εK-KKK-MvF5 Th (UB311 immunogen I) is a biologically active peptide and one of the Aβ1–14 targeting peptides (B-cell epitope) used in UB-311.</p>Fórmula:C199H318N56O55Peso molecular:4372.38081Amyloid β-Protein (1-24)
CAS:<p>Amyloid β-Protein (1-24) is a peptide identified through peptide screening. This tool predominantly employs immunoassays to gather and analyze active peptides. Peptide screening is utilized in studies involving protein interactions, functional analysis, and epitope screening, particularly relevant in the research and development of active molecules.</p>Fórmula:C130H183N35O40Peso molecular:2876.05Aβ-IN-6
<p>Aβ-IN-6 is an orally active compound exhibiting anti-inflammatory, antioxidant, and anti-oligomeric activities, with significant implications for Alzheimer's</p>Fórmula:C28H31N3O4Forma y color:SolidPeso molecular:473.56FITC-β-Ala-Amyloid β-Protein (1-42) (ammonium)
<p>FITC-β-Ala-Amyloid β-Protein (1-42) (ammonium) is a FITC-labeled amyloid beta monomer, Alzheimer’s research, drug screening, and biomolecular studies.</p>Fórmula:C227H330N58O66S2Forma y color:SolidPeso molecular:4991.53β-Amyloid (29-40)
CAS:<p>β-Amyloid (29-40) is a fragment of Amyloid-β peptide.Alzheimer's beta amyloid peptide (29-40/42) C-terminal fragments have physical and chemical properties</p>Fórmula:C49H88N12O13SPureza:98%Forma y color:SolidPeso molecular:1085.362002-H20
CAS:<p>2002-H20 is an Aβ42-induced cytotoxicity inhibitor. It acts by binding the Alzheimer's Aβ peptide and reducing its cytotoxicity.</p>Fórmula:C20H15N3O3Pureza:98%Forma y color:SolidPeso molecular:345.358β-Amyloid (22-35)
CAS:<p>β-Amyloid (22-35) is a 14-aa peptide, shows aggregates and induces neurotoxicity in the hippocampal cells.</p>Fórmula:C59H102N16O21SPureza:98%Forma y color:SolidPeso molecular:1403.62β-Amyloid (1-38), mouse, rat
CAS:<p>β-Amyloid (1-38), derived from mice and rats, is a chemical compound comprising 38 amino acids, specifically residues 1-38 of the Aβ peptide.</p>Forma y color:SolidAducanumab
CAS:<p>Aducanumab (BIIB037) is an IgG1 antibody targeting amyloid beta to treat Alzheimer's; it's brain-permeable.</p>Pureza:95% - 97.10%Forma y color:LiquidPeso molecular:145.93 kDaAβ-IN-7
<p>Aβ-IN-7 (compound 5a) acts as a potent inhibitor of Aβ aggregation, stabilizing Aβ monomers at 50 μM concentration to prevent them from forming larger oligomers</p>Fórmula:C14H10N2SForma y color:SolidPeso molecular:238.31γ-Secretase Modulators
CAS:<p>gamma-Secretase Modulators serves as a useful treatment for Alzheimer's disease by inhibiting the production of Amyloid-β.</p>Fórmula:C26H24F3N3O3Pureza:98%Forma y color:SolidPeso molecular:483.48β-Amyloid (1-34)
CAS:<p>This is a fragment of beta-amyloid peptide. It has amino acids 1 through 34.</p>Fórmula:C170H253N47O52Pureza:98%Forma y color:SolidPeso molecular:3787.2Amyloid-Forming peptide GNNQQNY
CAS:<p>Amyloid-Forming peptide GNNQQNY, a biologically active heptapeptide derived from the N-terminal prion-determining domain of yeast Sup35, is instrumental in</p>Fórmula:C33H48N12O14Forma y color:SolidPeso molecular:836.81(Met(O)35)-Amyloid β-Protein (1-42)
<p>(Met(O)35)-Amyloid β-Protein (1-42) represents the oxidized form of Methionine 35 in Aβ42, capable of producing an oligomer size distribution akin to that of</p>Fórmula:C203H311N55O61SForma y color:SolidPeso molecular:4530.04Biphenyl-3′,3,4,4′-tetrol
CAS:<p>Biphenyl-3′,3,4,4′-tetrol (BPT) is a potent inhibitor of Aβ40 aggregation and can be utilized in research related to neurodegenerative diseases such as Alzheimer's.</p>Fórmula:C12H10O4Forma y color:SolidPeso molecular:218.21Glycerophosphorylethanolamine (sodium salt)
CAS:<p>Glycerophosphorylethanolamine, a phosphatidylethanolamine metabolite, elevates in Alzheimer's and promotes Aβ40 aggregation.</p>Fórmula:C5H13NNaO6PForma y color:SolidPeso molecular:237.12G923-0271
CAS:<p>G923-0271 is a TDP-43 inhibitor that improves disease phenotypes in TDP-43 nematode models and reduces the overexpression of human TDP-43, ALS FTD.</p>Fórmula:C28H23FN4OForma y color:SolidPeso molecular:450.51β-Amyloid (4-10)
CAS:<p>Antibodies corresponding to beta-amyloid (4-10) are effective in vivo inhibitors of cytotoxicity, amyloid plaque formation and special memory disturbances in</p>Fórmula:C39H52N12O12Pureza:98%Forma y color:SolidPeso molecular:880.9β-Amyloid (35-25)
CAS:<p>β-Amyloid (35-25) is the reverse sequence of β-Amyloid (25-35).</p>Fórmula:C45H81N13O14SPeso molecular:1060.27FITC-β-Ala-Amyloid β-Protein (1-42)
CAS:<p>FITC-β-Ala-Amyloid β-Protein (1-42) is a polypeptide identified through peptide screening. This screening method predominantly utilizes immunoassays to gather active polypeptides and is used in studying protein interactions, conducting functional analyses, and screening antigen epitopes, with particular application in the research and development of active molecules.</p>Fórmula:C227H327N57O66S2Peso molecular:4971.34251RAGE antagonist peptide
CAS:<p>RAGE antagonist blocks S100P/A4, HMGB-1; hinders glioma growth, metastasis; reduces PDAC cell growth, NF-κB activity; counters TDI effects in mice.</p>Fórmula:C57H101N13O17SPureza:98%Forma y color:SolidPeso molecular:1272.56Dalidnetug
CAS:<p>Dalidnetug is a humanized monoclonal antibody that targets human β-amyloid precursor protein (APP). By specifically binding to APP, Dalidnetug reduces the production of β-amyloid (Aβ), thereby demonstrating activity in clearing β-amyloid. This compound holds potential for research in Alzheimer's disease.</p>Forma y color:LiquidSQ-3
<p>SQ-3, a quinoline analogue, prefers α-syn (Ki=39.3nM) to Aβ (Ki=230nM), and [18F]SQ3 is a lead for α-syn probes. [1]</p>Fórmula:C21H21FN2OForma y color:SolidPeso molecular:336.4β-Amyloid (1-28)
CAS:<p>β-Amyloid (1-28) is a β-Amyloid protein fragment involved in metal binding.</p>Fórmula:C145H209N41O46Pureza:98%Forma y color:SolidPeso molecular:3262.51β-Amyloid (10-35), amide
CAS:<p>β-Amyloid (10-35), amide, is a chemical compound consisting of 26 amino acids, specifically residues 10-35 of the Aβ peptide.</p>Fórmula:C133H205N35O36SPureza:98%Forma y color:SolidPeso molecular:2902.33β-Amyloid (1-11)
CAS:<p>Anionic interaction of Beta-amyloid (1-11) with Factor XII is suspected to cause massive activation of the C4 (complement 4) system in the cerebrospinal fluid</p>Fórmula:C56H76N16O22Pureza:98%Forma y color:SolidPeso molecular:1325.3β-Amyloid (12-20)
CAS:<p>β-Amyloid (12-20) is a peptide fragment of β-Amyloid.Thsis peptide contain the amino acid residues VFF at position (18-20), suggesting that this triad has</p>Fórmula:C57H83N15O11Pureza:98%Forma y color:SolidPeso molecular:1154.36β-Amyloid (1-43)(human) TFA
<p>β-Amyloid (1-43)(human) TFA exhibits greater aggregation tendencies and heightened toxicity compared to its well-established counterpart, Aβ1-42.</p>Fórmula:C209H319F3N56O64SForma y color:SolidPeso molecular:4729.21Crenezumab
CAS:<p>Crenezumab (MABT 5102A) is a fully humanized anti-amyloid-beta antibody that binds to multiple forms of amyloid-beta (Aβ) for the study of Alzheimer's disease.</p>Pureza:97.5% (SDS-PAGE); 95.3% (SEC-HPLC) - 97.5% (SDS-PAGE); 95.3% (SEC-HPLC)Forma y color:LiquidJNK3 inhibitor-9
<p>JNK3inhibitor-9 (Compound 24a) is a potent, selective JNK3 inhibitor capable of crossing the blood-brain barrier (BBB), demonstrating an IC50 value of 12 nM. It effectively inhibits GSK3α/β, which is involved in Tau phosphorylation, with IC50 values of 14 nM and 35 nM, respectively. JNK3inhibitor-9 also reduces the phosphorylation of c-Jun and APP and protects neurons from Aβ1-42 toxicity.</p>Fórmula:C25H27N7O2Forma y color:SolidPeso molecular:457.528(D-Asp1)-Amyloid β-Protein (1-42)
CAS:<p>(D-Asp1)-Amyloid β-Protein (1-42), a peptide fragment of amyloid β-protein (Aβ), serves as the primary constituent of vascular and parenchymal amyloid deposits</p>Fórmula:C203H311N55O60SForma y color:SolidPeso molecular:4514.04Biotin-β-Amyloid (1-42), human TFA
<p>Biotin-β-Amyloid (1-42), human TFA, also known as Biotin-Amyloid β-Peptide (1-42) (human) TFA, is a biotin-labeled 42-amino acid peptide implicated in the</p>Fórmula:C215H326F3N57O64S2Forma y color:SolidPeso molecular:4854.36AChE/Aβ-IN-6
<p>BACE1-IN-15 (compound 4j) serves as an effective inhibitor of BACE1 (β-secretase), efficiently mitigating the copper-induced toxicity of Aβ, with an EC50 value of 0.68 μM.</p>Forma y color:Odour Solid(Met(O2)35)-Amyloid β-Protein (1-42)
<p>(Met(O2)35)-Amyloid β-Protein (1-42) is a peptide [1] .</p>Fórmula:C203H311N55O62SForma y color:SolidPeso molecular:4546.04(Glu20)-Amyloid β-Protein (1-42)
CAS:<p>(Glu20)-Amyloid β-Protein (1-42) represents a variant of amyloid β-protein (Aβ) that fibrillizes more slowly.</p>Fórmula:C199H309N55O62SForma y color:SolidPeso molecular:4495.98DDC 2′,3′-O-disulfate
<p>DDC 2′,3′-O-disulfate (compound 4) inhibits the fibrillization and oligomerization of Aβ42, showing promise for Alzheimer's disease (AD) research [1].</p>Fórmula:C17H16O11S2Forma y color:SolidPeso molecular:460.43β-Amyloid (22-40)
CAS:<p>This synthetic peptide consists of amino acids 22 to 40 of beta amyloid protein.</p>Fórmula:C78H135N21O26SPureza:98%Forma y color:SolidPeso molecular:1815.1Amyloid β-Protein (3-42)
CAS:<p>Amyloid β-Protein (3-42), the precursor of Pyr peptide, serves as the foundation of the amyloid template block in Alzheimer's disease when modified to</p>Forma y color:Solidβ-Amyloid (13-27)
CAS:<p>β-Amyloid (13-27) is a peptide consisting of amino acid of 13 to 27 of beta amyloid protein.</p>Fórmula:C84H126N24O24Pureza:98%Forma y color:SolidPeso molecular:1856.05C18 L-erythro Ceramide (d18:1/18:0)
CAS:<p>C18 L-erythro Ceramide, a natural stereoisomer, inhibits rat brain mt-CDase with IC50 of 8.8 μM.</p>Fórmula:C36H71NO3Forma y color:SolidPeso molecular:565.95Aβ-IN-8
<p>Aβ-IN-8, also known as compound 7e, is a potent inhibitor of Aβ aggregation [1].</p>Fórmula:C22H16F3N3O3SForma y color:SolidPeso molecular:459.44β-Amyloid (11-22)
CAS:<p>β-Amyloid (11-22) is a peptide fragment of β-Amyloid.Beta-amyloid peptide (Abeta), the major constituent of amyloid plaques in the brains of Alzheimer’s</p>Fórmula:C70H102N18O18Pureza:98%Forma y color:SolidPeso molecular:1483.677-Deoxy-trans-dihydronarciclasine
CAS:<p>7-Deoxy-trans-dihydronarciclasine is an alkaloid that functions as a tobacco mosaic virus (TMV) inhibitor with an IC50 of 1.80 μM and also serves as an anti-</p>Fórmula:C14H15NO6Forma y color:SolidPeso molecular:293.27p-HTAA
CAS:<p>Pentamer Hydrogen Thiophene Acetic Acid (p-HTAA) is a compound that specifically targets and labels amyloid-beta (Aβ) deposits in the brains of living mice [1].</p>Fórmula:C24H16O4S5Forma y color:SolidPeso molecular:528.71mcK6A1
<p>mcK6A1 serves as an inhibitor of amyloid-β (Aβ) aggregation, selectively binding to the 16KLVFFA21 fragment of Aβ42, leading to the formation of an extended β-sheet structure and preventing the formation of Aβ42 oligomers. This compound is valuable for research into Alzheimer's disease and other amyloid-related disorders.</p>Fórmula:C71H99N17O16Forma y color:SolidPeso molecular:1446.65β-Amyloid (1-16)
CAS:<p>β-Amyloid (1-16) is an amyloidogenic protein fragment with a sequence derived from β-amyloid.</p>Fórmula:C84H119N27O28Pureza:98%Forma y color:SolidPeso molecular:1955.04β-Amyloid (33-40)
CAS:<p>β-Amyloid (33-40) is a peptide comprising amino acids 33 to 40 of the beta-amyloid protein.</p>Fórmula:C32H58N8O9SPureza:98%Forma y color:SolidPeso molecular:730.92AC 253
CAS:<p>Amylin (AMY3) receptor antagonist; blocks cAMP, Ca2+, PKA, MAPK, Akt, and cFOS activity; prevents Aβ-induced neuronal death. Cyclic AC 253 variant exists.</p>Fórmula:C122H196N40O39Pureza:98%Forma y color:SolidPeso molecular:2847.11Acetyl-Tau Peptide (273-284) amide
CAS:<p>Acetyl-Tau Peptide (273-284) amide inhibits Ac-Aβ(25–35)-NH2 aggregation and models Aβ/Tau interaction.</p>Fórmula:C64H116N18O17Forma y color:SolidPeso molecular:1409.72β-Amyloid (1-9)
CAS:<p>This is an N-terminal fragment of beta amyloid.</p>Fórmula:C42H60N14O17Pureza:98%Forma y color:SolidPeso molecular:1033.01Chemerin-9 (149-157) TFA
<p>Chemerin-9 (149-157) TFA is a peptide located at positions 149-157 of chemerin-9, acting as a ChemR23/CMKLR1 agonist.</p>Fórmula:C56H67F3N10O15Pureza:99.77%Forma y color:SolidPeso molecular:1177.18CHF-5022
CAS:<p>CHF-5022 is a nonsteroidal anti-inflammatory drug that selectively inhibits the production of beta-amyloid protein (1-42) (ABETA42).</p>Fórmula:C17H12F4O2Forma y color:SolidPeso molecular:324.27β-Amyloid Protein Precursor 770 (135-155)
CAS:<p>Beta-Amyloid Protein Precursor 770 (135-155)Aβ Protein Precursor 770 (135-155)</p>Fórmula:C116H172N35O31S2Pureza:98%Forma y color:SolidPeso molecular:2617.962,3-Dehydrosilybin A
CAS:<p>2,3-Dehydrosilybin A is a useful organic compound for research related to life sciences and the catalog number is T125202.</p>Fórmula:C25H20O10Forma y color:SolidPeso molecular:480.425GSK-3β inhibitor 27
<p>GSK-3β inhibitor27 (Compound 1c) is a reversible, competitive inhibitor of GSK-3β with an IC50 value of 2.2 μM. It inhibits tau hyperphosphorylation and reduces Aβ protein aggregation, demonstrating metal chelation and neuroprotective potential. GSK-3β inhibitor27 is promising for research into neurodegenerative diseases, such as Alzheimer's disease.</p>Fórmula:C16H17ClN4O2Forma y color:SolidPeso molecular:332.79Anti-Amyloid β Antibody (scFv59)
<p>Anti-Amyloid Beta Antibody (scFv59) is a human-derived antibody produced in CHO cells that targets Amyloid-β. For isotype control, please refer to Human IgG1 kappa, Isotype Control.</p>Forma y color:Odour Liquid5-FAM-β-Amyloid (1-28)
<p>5-FAM-β-Amyloid (1-28) is a fluorescently-labeled peptide corresponding to the first 28 amino acids of the β-Amyloid protein.</p>Fórmula:C166H219N41O52Forma y color:SolidPeso molecular:3620.76β-Amyloid (1-17)
CAS:<p>This synthetic peptide consists of amino acids 1 to 17 of beta amyloid protein. This peptide can be employed in beta amyloid solubility studies.</p>Fórmula:C90H130N28O29Pureza:98%Forma y color:SolidPeso molecular:2068.2Methoxy-X04
CAS:<p>Methoxy-X04, a derivative of Congo red and Chrysamine-G, is a brain-permeable fluorescent probe for amyloid-β (Aβ).</p>Fórmula:C23H20O3Pureza:98.96%Forma y color:SolidPeso molecular:344.41H-Indole-3-carboxylic acid, 5-[2-hydroxy-3-[[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]amino]propoxy]-2-methyl-1-(4-methylphenyl)-, ethyl ester
CAS:<p>Compound 5936-0108对β-淀粉样蛋白可能具有调节作用。</p>Fórmula:C26H34N2O7Pureza:99.44%Forma y color:SoildPeso molecular:486.56β-Amyloid (12-28)
CAS:<p>Amyloid β-peptide fragment; minimum section required to bind to brain proteins.</p>Fórmula:C89H135N25O25Pureza:98%Forma y color:SolidPeso molecular:1955.18AZD4694 Precursor
CAS:<p>AZD4694 Precursor used for synthesizing [18F]AZD4694, a high-affinity amyloid-β imaging agent.</p>Fórmula:C22H25N3O7Forma y color:SolidPeso molecular:443.45Biotinoyl tripeptide-1
CAS:<p>Biotinoyl tripeptide-1 can produce hair follicles by promoting scalp micro-circulation and reduce follicle atrophy and aging.</p>Fórmula:C24H38N8O6SPureza:98%Forma y color:SolidPeso molecular:566.67β-Amyloid (18-28)
CAS:<p>Intracerebroventricular administration of synthetic peptides Beta-amyloid (12-20), (12-28), and (18-28) causes amnesia in mice.</p>Fórmula:C55H81N13O18Pureza:98%Forma y color:SolidPeso molecular:1212.31β-Amyloid (10-20)
CAS:<p>Amyloid β-Protein (10-20) is a fragment of Amyloid-β peptide, maybe used in the research of neurological disease.Amyloid β protein fragment containing the α-</p>Fórmula:C71H99N17O16Pureza:98%Forma y color:Lyophilized PowderPeso molecular:1446.65Sabirnetug
CAS:<p>Sabirnetug is a humanized IgG2κ monoclonal antibody that specifically targets the amyloid-β (A4) precursor protein.</p>Forma y color:Liquidβ-Amyloid (1-20)
CAS:<p>This synthetic peptide consists of amino acids 1 to 20 of beta amyloid protein.</p>Fórmula:C113H157N31O32Pureza:98%Forma y color:SolidPeso molecular:2461.7Davunetide
CAS:<p>Davunetide: neuroprotective 8-amino acid peptide, improves daily function in schizophrenia, boosts memory in mild cognitive impairment.</p>Fórmula:C36H60N10O12Pureza:98%Forma y color:SolidPeso molecular:824.92SEN177
CAS:<p>SEN177 shows the potential in the research of Huntington's disease that is a potent inhibitor of glutaminyl cyclase (QPCT) with an IC 50 of 0.013μM for glutaminyl-peptide cyclotransferase-like (QPCTL). The Ki value of SEN177 for human glutaminyl cyclase (hQC) is 20 nM. SEN177 significantly reduces the early stages of mutant HTT oligomerisation and reduces the percentage of neurons with Q80 aggregates [1].</p>Fórmula:C18H19FN6Forma y color:SolidPeso molecular:338.38TH-237A
CAS:<p>TH-237A is a novel neuroprotective agent exhibiting favorable permeation across the blood-brain barrier.</p>Fórmula:C18H17F2NO3Pureza:98%Forma y color:SolidPeso molecular:333.335AZD4694
CAS:<p>Flutafuranol (AZD4694/NAV4694) binds beta-amyloid, potential PET tracer for Alzheimer's. Non-F18 version supplied.</p>Fórmula:C14H11FN2O2Forma y color:SolidPeso molecular:258.25(Rac)-Z-Phe-Phe-FMK
CAS:<p>(Rac)-Z-Phe-Phe-FMK (Cathepsin L-IN-2) is a cathepsin L inhibitor that inhibits the tendency of β-amyloid to induce apoptotic changes .</p>Fórmula:C27H27FN2O4Pureza:98.27%Forma y color:SolidPeso molecular:462.51Cu(II)GTSM
CAS:<p>Cu(II)GTSM is a cell permeable copper complex inhibits GSK3β activity and suppresses levels of neurotoxic amyloid β-trimers and phosphorylated tau.</p>Fórmula:C6H10CuN6S2Pureza:99.21%Forma y color:SolidPeso molecular:293.86Begacestat
CAS:<p>Begacestat (GSI-953) is a potent and selective gamma-secretase inhibitor that inhibits Amyloid-beta, inhibits cleavage of APP,,Alzheimer's disease.</p>Fórmula:C9H8ClF6NO3S2Forma y color:SolidPeso molecular:391.74Pyridoxal 5'-phosphate hydrate
CAS:<p>Pyridoxal 5'-phosphate hydrate (PLP)(1:x), the active form of vitamin B6, is a cofactor for many different enzymes involved in transamination reactions,</p>Fórmula:C8H10NO6PPureza:97.52%Forma y color:SolidPeso molecular:247.141,1'-Methylenedi-2-naphthol
CAS:<p>1,1'-Methylenedi-2-naphthol target CYP2C19 - cytochrome P450 family 2 subfamily C member 19 (human).</p>Fórmula:C21H16O2Pureza:98.91%Forma y color:Light Pink To Light Brown Crystalline PowderPeso molecular:300.35Miridesap
CAS:<p>Miridesap (GSK2315698) rapidly depletes SAP in blood, cerebrospinal fluid, and amyloid deposits via liver clearance.</p>Fórmula:C16H24N2O6Pureza:≥95%Forma y color:SolidPeso molecular:340.37PiB
CAS:<p>PiB (Pittsburgh Compound-B) is a standard for analysis of 11C-PiB. 11C-PiB is a β-amyloid PET imaging tracer for Alzheimer's disease diagnosis.</p>Fórmula:C14H12N2OSPureza:97.02%Forma y color:SolidPeso molecular:256.32CRANAD 2
CAS:<p>CRANAD-2, a near-infrared probe, detects amyloid-beta in vivo, increasing fluorescence 70x and shifting blue 90 nm upon binding.</p>Fórmula:C23H25BF2N2O2Pureza:99.44%Forma y color:Dark Blue To Black PowderPeso molecular:410.27Anle138b
CAS:<p>Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease</p>Fórmula:C16H11BrN2O2Pureza:98.88% - 99.82%Forma y color:SolidPeso molecular:343.17

